{"url_path":"/sec/allr/8-k/2026-06-02/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 (e)*","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-02","source_url":"https://www.sec.gov/Archives/edgar/data/1860657/0001213900-26-064278-index.html","accession_number":"0001213900-26-064278","cik":"0001860657","ticker":"ALLR","issuer_name":"Allarity Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1860657/0001213900-26-064278-index.html","primary_entity_key":"0001860657","primary_entity_name":"Allarity Therapeutics, Inc."},"word_count":563,"has_tables":true,"body_markdown":"* *\n\n*Item 5.02(e)*\n\n \n\nAs previously disclosed, effective\nJune 1, 2024, Allarity Therapeutics, Inc., a Delaware corporation (the “Company”), entered into a Management Services Agreement\n(the “Original MSA”) with Ljungaskog Consulting AB, a Swedish limited liability company (the “Consultant”), owned\nand managed by Thomas H. Jensen (“Mr. Jensen”), the Company’s Chief Executive Officer. Effective as of June 1,\n2026 (the “A&R Effective Date”), the Company entered into an Amended and Restated Management Services Agreement (the “A&R\nMSA”) with the Consultant. The A&R MSA amends and restates the Original MSA in its entirety. Except as described below, the\nmaterial terms of the A&R MSA are substantially consistent with the material terms of the Original MSA previously disclosed by the\nCompany.\n\n* *\n\n*Base Compensation and Bonus.*\nUnder the A&R MSA, the Monthly Fee is payable in accordance with Attachment B to the A&R MSA, which provides that the Consultant’s\nannual base salary for 2026 will be paid 80% in Swedish Krona and 20% in U.S. dollars, equal to SEK 6,000,000 and US$163,043. The A&R\nMSA eliminates the one-time $100,000 signing bonus provided under the Original MSA. The A&R MSA further provides that the Company\nshall endeavor to issue new annual bonus performance metrics on or before March 31 of each calendar year and, if no new metrics are issued\nby that date, the prior calendar year’s bonus performance metrics will apply. The annual bonus will be capped at 60% of the Monthly\nFees paid to the Consultant in a calendar year. If earned, any annual bonus is payable on or before March 15 following the end of the\napplicable calendar year.\n\n* *\n\n*Termination for Convenience\nby the Company.* The A&R MSA increases the Company’s notice period for a termination for convenience from 15 days to 30 days.\nIn addition, upon a termination by the Company for convenience, the Consultant is entitled to the Accrued Payments and a “Termination\nPayment” equal to 12 months of the Monthly Fee, payable in semi-monthly installments, subject to the Consultant’s compliance\nwith surviving obligations, execution of a general release of claims, and cooperation with transition matters and Company investigations\nduring the payment period. Under the Original MSA, upon a termination by the Company for convenience, the Consultant was entitled only\nto the Accrued Payments.\n\n* *\n\n*Other Termination Changes.*\nThe A&R MSA provides that, upon a termination by the Consultant for convenience, the Company may waive all or a portion of the Consultant’s\n30-day notice period. The A&R MSA further provides that, upon a termination by the Consultant for Good Reason, the Consultant is entitled\nto the Accrued Payments plus the Termination Payment, subject to the Consultant’s compliance with surviving obligations and execution\nof a general release of claims. Under the Original MSA, upon a termination for Good Reason, the Consultant was entitled to the Accrued\nPayments plus an additional nine months of the Monthly Fee, subject to similar release and continuing-obligation conditions.\n\n* *\n\n*Additional Provisions.*\nThe A&R MSA adds provisions addressing Section 409A and Section 280G of the Internal Revenue Code, in each case if the Consultant\nis subject to federal income taxation in the United States at the applicable time.\n\n \n\nThe foregoing description\nof the A&R MSA does not purport to be complete and is qualified in its entirety by reference to the full text of the A&R MSA,\na copy of which is filed as Exhibit 10.1 hereto and is incorporated herein by reference."}